Brad A. Racette, M.D. - Publications

Affiliations: 
Neurology Washington University, Saint Louis, St. Louis, MO 
Area:
Movement disorders, Epidemiology
Website:
http://neuro.wustl.edu/aboutus/facultybiographies/racette/

117 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Krzyzanowski B, Nielsen SS, Turner JR, Racette BA. Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology. PMID 37903644 DOI: 10.1212/WNL.0000000000207871  0.365
2022 Martin WRW, Younce JR, Campbell MC, Racette BA, Norris SA, Ushe M, Criswell S, Davis AA, Alfradique-Dunham I, Maiti B, Cairns NJ, Perrin RJ, Kotzbauer PT, Perlmutter JS. Neocortical Lewy body pathology parallels Parkinson's dementia, but not always. Annals of Neurology. PMID 36331161 DOI: 10.1002/ana.26542  0.789
2022 Racette BA, Nelson G, Dlamini WW, Hershey T, Prathibha P, Turner JR, Checkoway H, Sheppard L, Searles Nielsen S. Environmental manganese exposure and cognitive control in a South African population. Neurotoxicology. 89: 31-40. PMID 34999155 DOI: 10.1016/j.neuro.2022.01.004  0.469
2021 Nielsen SS, Warden MN, Sallmén M, Sainio M, Uuksulainen S, Checkoway H, Hublin C, Racette BA. Solvent exposed occupations and risk of Parkinson disease in Finland. Clinical Parkinsonism & Related Disorders. 4: 100092. PMID 34316670 DOI: 10.1016/j.prdoa.2021.100092  0.34
2021 Racette BA, Nelson G, Dlamini WW, Hershey T, Prathibha P, Turner JR, Checkoway H, Sheppard L, Nielsen SS. Depression and anxiety in a manganese-exposed community. Neurotoxicology. PMID 34087333 DOI: 10.1016/j.neuro.2021.05.017  0.463
2021 Dlamini WW, Nielsen S, Ushe M, Nelson G, Racette BA. A Rapid Motor Task-Based Screening Tool for Parkinsonism in Community-Based Studies. Frontiers in Neurology. 12: 653066. PMID 34054697 DOI: 10.3389/fneur.2021.653066  0.738
2021 Racette BA, Nelson G, Dlamini WW, Prathibha P, Turner JR, Ushe M, Checkoway H, Sheppard L, Nielsen SS. Severity of parkinsonism associated with environmental manganese exposure. Environmental Health : a Global Access Science Source. 20: 27. PMID 33722243 DOI: 10.1186/s12940-021-00712-3  0.749
2020 Martin WRW, Miles M, Zhong Q, Hartlein J, Racette BA, Norris SA, Ushe M, Maiti B, Criswell S, Davis AA, Kotzbauer PT, Cairns NJ, Perrin RJ, Perlmutter JS. Is Levodopa Response a Valid Indicator of Parkinson's Disease? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33253432 DOI: 10.1002/mds.28406  0.785
2020 Nelson G, Ndlovu N, Christofides N, Hlungwani TM, Faust I, Racette BA. Validation of Parkinson's Disease-Related Questionnaires in South Africa. Parkinson's Disease. 2020: 7542138. PMID 32617145 DOI: 10.1155/2020/7542138  0.336
2020 Criswell SR, Nielsen SS, Warden MN, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. PMID 32472844 DOI: 10.1097/Jom.0000000000001915  0.386
2020 Faust IM, Racette BA, Searles Nielsen S. Validation of a Parkinson Disease Predictive Model in a Population-Based Study. Parkinson's Disease. 2020: 2857608. PMID 32148753 DOI: 10.1155/2020/2857608  0.376
2020 Silver MR, Racette BA, Dube U, Faust IM, Searles Nielsen S. Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study. Journal of Parkinson's Disease. PMID 32083591 DOI: 10.3233/Jpd-191793  0.349
2019 Fan J, Searles Nielsen S, Faust IM, Racette BA. Transplant and risk of Parkinson disease. Parkinsonism & Related Disorders. PMID 30827837 DOI: 10.1016/j.parkreldis.2019.02.013  0.303
2018 Criswell SR, Warden MN, Searles Nielsen S, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. Selective D2 receptor PET in manganese-exposed workers. Neurology. PMID 30097475 DOI: 10.1212/Wnl.0000000000006163  0.423
2018 Camacho-Soto A, Gross A, Searles Nielsen S, Dey N, Racette BA. Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries. Parkinsonism & Related Disorders. PMID 29459115 DOI: 10.1016/j.parkreldis.2018.02.008  0.379
2018 Racette BA. 1714a Parkinsonism predictive model in mn-exposed workers Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.825  0.373
2018 Racette BA. 1713d Occupational exposure to solvents and risk of parkinson disease in finland Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.810  0.466
2018 Nelson G, Racette BA. 1387 Correlation between clinical assessment of parkinsonism, self-reported symptoms and motor dysfunction in a manganese-exposed community Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.1450  0.442
2018 Dlamini WW, Nelson G, Racette BA. 1367 The association between parkinsonism and quality of life in south african manganese mine workers Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.1434  0.405
2018 Sallmén M, Warden M, Uuksulainen S, Racette B, Sainio M, Searles Nielsen S. Risk of Parkinson disease in agricultural occupations in Finland Revue D'éPidéMiologie Et De Santé Publique. 66: S264. DOI: 10.1016/J.Respe.2018.05.077  0.47
2017 Camacho-Soto A, Warden MN, Searles Nielsen S, Salter A, Brody DL, Prather H, Racette BA. Traumatic Brain Injury in the Prodromal Period of Parkinson Disease: A Large Epidemiological Study Using Medicare Data. Annals of Neurology. PMID 29024046 DOI: 10.1002/ana.25074  0.328
2017 Searles Nielsen S, Warden MN, Camacho-Soto A, Willis AW, Wright BA, Racette BA. A predictive model to identify Parkinson disease from administrative claims data. Neurology. PMID 28864676 DOI: 10.1212/WNL.0000000000004536  0.338
2017 Criswell SR, Nielsen SS, Warden M, Perlmutter JS, Moerlein SM, Flores HP, Huang J, Sheppard L, Seixas N, Checkoway H, Racette BA. [(18)F]FDOPA Positron Emission Tomography in Manganese-Exposed Workers. Neurotoxicology. PMID 28694016 DOI: 10.1016/J.Neuro.2017.07.004  0.548
2017 Racette BA, Gross A, Criswell SR, Checkoway H, Nielsen SS. A Screening Tool to Detect Clinical Manganese Neurotoxicity. Neurotoxicology. PMID 28274800 DOI: 10.1016/J.Neuro.2017.02.009  0.373
2017 Martin WR, Hartlein J, Racette BA, Cairns N, Perlmutter JS. Pathologic correlates of supranuclear gaze palsy with parkinsonism. Parkinsonism & Related Disorders. PMID 28256434 DOI: 10.1016/J.Parkreldis.2017.02.027  0.553
2016 Racette BA, Searles Nielsen S, Criswell SR, Sheppard L, Seixas N, Warden MN, Checkoway H. Dose-dependent progression of parkinsonism in manganese-exposed welders. Neurology. PMID 28031394 DOI: 10.1212/Wnl.0000000000003533  0.341
2016 Al-Lozi A, Nielsen SS, Hershey T, Birke A, Checkoway H, Criswell SR, Racette BA. Cognitive control dysfunction in workers exposed to manganese-containing welding fume. American Journal of Industrial Medicine. PMID 27862095 DOI: 10.1002/Ajim.22675  0.53
2016 Davis AA, Racette B. Parkinson disease and cognitive impairment: Five new things. Neurology. Clinical Practice. 6: 452-458. PMID 27847686 DOI: 10.1212/CPJ.0000000000000285  0.302
2016 Nelson G, Racette B. P205 Measuring the health effects of manganese smelter emissions in south africa: a pilot study Occupational and Environmental Medicine. 73. DOI: 10.1136/Oemed-2016-103951.521  0.365
2015 Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging. PMID 26601739 DOI: 10.1016/J.Neurobiolaging.2015.09.014  0.638
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Racette B, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.432
2015 Safarpour D, Thibault DP, DeSanto CL, Boyd CM, Dorsey ER, Racette BA, Willis AW. Nursing home and end-of-life care in Parkinson disease. Neurology. 85: 413-9. PMID 26138947 DOI: 10.1212/Wnl.0000000000001715  0.332
2015 Racette BA, Willis AW. Time to change the blind men and the elephant approach to Parkinson disease? Neurology. 85: 190-6. PMID 26070339 DOI: 10.1212/Wnl.0000000000001739  0.393
2015 Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. The Lancet. Neurology. 14: 710-9. PMID 26025783 DOI: 10.1016/S1474-4422(15)00058-7  0.303
2015 Checkoway H, Nielsen SS, Racette BA. Epidemiological studies of parkinsonism in welders Issues in Toxicology. 2015: 513-523.  0.37
2014 Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Franklin GM, Swanson PD, Smith-Weller T, Racette BA, Checkoway H. Formulations of hormone therapy and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1631-6. PMID 25255692 DOI: 10.1002/Mds.26037  0.357
2014 Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzi?ska M, Mom?ilovi? D, et al. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Molecular Genetics & Genomic Medicine. 2: 261-72. PMID 24936516 DOI: 10.1002/Mgg3.67  0.467
2014 Harris-Hayes M, Willis AW, Klein SE, Czuppon S, Crowner B, Racette BA. Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures. The Journal of Bone and Joint Surgery. American Volume. 96: e27. PMID 24553896 DOI: 10.2106/Jbjs.L.01317  0.319
2014 Gonzalez-Cuyar LF, Nelson G, Criswell SR, Ho P, Lonzanida JA, Checkoway H, Seixas N, Gelman BB, Evanoff BA, Murray J, Zhang J, Racette BA. Quantitative neuropathology associated with chronic manganese exposure in South African mine workers. Neurotoxicology. 45: 260-6. PMID 24374477 DOI: 10.1016/J.Neuro.2013.12.008  0.316
2014 Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 82: 163-71. PMID 24336138 DOI: 10.1212/Wnl.0000000000000017  0.595
2014 Racette BA. Manganism in the 21st century: the Hanninen lecture. Neurotoxicology. 45: 201-7. PMID 24148923 DOI: 10.1016/J.Neuro.2013.09.007  0.47
2014 Lundin JI, Checkoway H, Criswell SR, Hobson AJ, Harris RC, Swisher LM, Evanoff BA, Racette BA. Screening for early detection of parkinsonism using a self-administered questionnaire: a cross-sectional epidemiologic study. Neurotoxicology. 45: 232-7. PMID 24035927 DOI: 10.1016/J.Neuro.2013.08.010  0.31
2014 Nielsen S, Checkoway H, Criswell S, Farin F, Racette B. 0239  Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders0239  Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders Occupational and Environmental Medicine. 71: A32.2-A32. DOI: 10.1136/Oemed-2014-102362.100  0.334
2013 Nichols MJ, Hartlein JM, Eicken MG, Racette BA, Black KJ. A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease. F1000research. 2: 150. PMID 24627787 DOI: 10.12688/F1000Research.2-150.V1  0.625
2013 Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C. Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiology of Aging. 34: 1519.e1-2. PMID 23116878 DOI: 10.1016/J.Neurobiolaging.2012.10.001  0.64
2013 Willis AW, Schootman M, Kung N, Racette BA. Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States Parkinsonism and Related Disorders. 19: 202-206. PMID 23083512 DOI: 10.1016/J.Parkreldis.2012.09.014  0.362
2012 Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/Srep00954  0.412
2012 Willis AW, Schootman M, Tran R, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 79: 1774-80. PMID 23054239 DOI: 10.1212/Wnl.0B013E3182703F92  0.608
2012 Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 33: 1356-61. PMID 22975422 DOI: 10.1016/J.Neuro.2012.08.011  0.645
2012 Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Archives of Neurology. 69: 1326-31. PMID 22825369 DOI: 10.1001/Archneurol.2012.1608  0.622
2012 Criswell SR, Perlmutter JS, Huang JL, Golchin N, Flores HP, Hobson A, Aschner M, Erikson KM, Checkoway H, Racette BA. Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occupational and Environmental Medicine. 69: 437-43. PMID 22447645 DOI: 10.1136/Oemed-2011-100119  0.491
2012 Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Archives of Neurology. 69: 394-7. PMID 22410448 DOI: 10.1001/Archneurol.2011.771  0.543
2012 Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Archives of Neurology. 69: 601-7. PMID 22213411 DOI: 10.1001/Archneurol.2011.2370  0.627
2012 Racette BA, Aschner M, Guilarte TR, Dydak U, Criswell SR, Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology. 33: 881-6. PMID 22202748 DOI: 10.1016/J.Neuro.2011.12.010  0.379
2012 Wright Willis A, Schootman M, Perlmutter J, Racette B. Neurologist Care in PD Is Associated with Fewer PD Related Hospitalizations (P02.242) Neurology. 78: P02.242-P02.242. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.242  0.594
2011 Zhu L, Cairns NJ, Tabbal SD, Racette BA. Pregnancy in multiple system atrophy: a case report. Journal of Medical Case Reports. 5: 599. PMID 22208291 DOI: 10.1186/1752-1947-5-599  0.37
2011 Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: A utilization, outcomes, and survival study Neurology. 77: 851-857. PMID 21832214 DOI: 10.1212/Wnl.0B013E31822C9123  0.601
2011 Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 76: 1296-301. PMID 21471467 DOI: 10.1212/Wnl.0B013E3182152830  0.539
2011 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 549-52. PMID 21370264 DOI: 10.1002/Mds.23551  0.488
2011 Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure Neurology. 76: 1296-1301. DOI: 10.1212/WNL.0b013e3182152830  0.441
2011 Lundin J, Checkoway H, Criswell S, Hobson A, Seixas N, Evanoff B, Sheppard L, Racette B. Increased risk of Parkinsonism associated with cumulative hours of welding Occupational and Environmental Medicine. 68: A7-A7. DOI: 10.1136/Oemed-2011-100382.20  0.395
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488297  0.425
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469. PMID 21488277  0.425
2010 Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, Racette BA. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. American Journal of Epidemiology. 172: 1357-63. PMID 20959505 DOI: 10.1093/Aje/Kwq303  0.38
2010 Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 34: 143-51. PMID 20090375 DOI: 10.1159/000275491  0.386
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. Novel THAP1 sequence variants in primary dystonia. Neurology. 74: 229-38. PMID 20083799 DOI: 10.1212/Wnl.0B013E3181Ca00Ca  0.509
2010 Criswell S, Sterling C, Swisher L, Evanoff B, Racette BA. Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders. Parkinsonism & Related Disorders. 16: 197-201. PMID 20005766 DOI: 10.1016/J.Parkreldis.2009.11.007  0.33
2010 Willis AW, Sterling C, Racette BA. Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysis. Parkinsonism & Related Disorders. 16: 163-6. PMID 19818671 DOI: 10.1016/J.Parkreldis.2009.09.002  0.497
2009 Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, ... ... Racette BA, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 41: 1308-12. PMID 19915575 DOI: 10.1038/Ng.487  0.612
2009 Racette BA, Good LM, Kissel AM, Criswell SR, Perlmutter JS. A population-based study of parkinsonism in an Amish community. Neuroepidemiology. 33: 225-30. PMID 19641327 DOI: 10.1159/000229776  0.627
2009 Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, et al. High-throughput mutational analysis of TOR1A in primary dystonia. Bmc Medical Genetics. 10: 24. PMID 19284587 DOI: 10.1186/1471-2350-10-24  0.496
2009 Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Parkinsonism & Related Disorders. 15: 175-80. PMID 18752982 DOI: 10.1016/J.Parkreldis.2008.05.004  0.631
2009 Galvin J, Burke W, Wang J, Racette B, Perlmutter J, Goate A. P3.029 Polymorphisms in aldehyde dehydrogenase and the risk of sporadic Parkinson disease Parkinsonism & Related Disorders. 15: S155. DOI: 10.1016/S1353-8020(09)70593-0  0.551
2008 Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32  0.615
2008 McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186  0.629
2008 DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4  0.629
2008 Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23  0.633
2008 Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics. 17: 759-67. PMID 18063669 DOI: 10.1093/Hmg/Ddm348  0.602
2007 Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. Association of α-synuclein gene haplotypes with Parkinson's disease Parkinsonism and Related Disorders. 13: 343-347. PMID 17292657 DOI: 10.1016/J.Parkreldis.2006.12.006  0.627
2007 Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, ... ... Racette B, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.Wnl.0000250355.28474.8E  0.402
2007 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. Reply from the authors [6] Neurology. 69: 495-496. DOI: 10.1212/01.wnl.0000279165.72261.d0  0.351
2006 Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, ... ... Racette BA, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1  0.619
2006 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. The impact of litigation on neurologic research. Neurology. 67: 2124-8. PMID 17190932 DOI: 10.1212/01.Wnl.0000249306.85048.86  0.461
2006 Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826  0.554
2006 Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1175-81. PMID 16673404 DOI: 10.1002/Mds.20919  0.696
2006 Racette BA, Good L, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Perlmutter JS. [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 245-9. PMID 16528749 DOI: 10.1002/Ajmg.B.30293  0.604
2006 Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology. 27: 357-61. PMID 16376428 DOI: 10.1016/J.Neuro.2005.11.005  0.574
2006 Racette BA, Perlmutter JS, Evanoff BA. Reply from the Authors [12] Neurology. 66: 617. DOI: 10.1212/01.Wnl.0000216108.57529.B1  0.424
2005 Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd  0.62
2005 Sinha R, Racette B, Perlmutter JS, Parsian A. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease Parkinsonism and Related Disorders. 11: 341-347. PMID 16019250 DOI: 10.1016/J.Parkreldis.2005.04.003  0.619
2005 Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, ... ... Racette BA, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515  0.618
2005 Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders Neurology. 64: 230-235. PMID 15668418 DOI: 10.1212/01.Wnl.0000149511.19487.44  0.603
2005 Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 492-6. PMID 15648057 DOI: 10.1002/Mds.20381  0.571
2004 Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS. Pathophysiology of parkinsonism due to hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1617-9. PMID 15489399 DOI: 10.1136/Jnnp.2003.028449  0.685
2004 Pastor P, Ezquerra M, Perez JC, Chakraverty S, Norton J, Racette BA, McKeel D, Perlmutter JS, Tolosa E, Goate AM. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Annals of Neurology. 56: 249-58. PMID 15293277 DOI: 10.1002/Ana.20178  0.535
2004 Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease Parkinsonism and Related Disorders. 10: 213-219. PMID 15120095 DOI: 10.1016/J.Parkreldis.2003.12.003  0.61
2004 Parsian A, Racette B, Zhang ZH, Rundle M, Perlmutter JS. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups Genomics. 83: 454-460. PMID 14962671 DOI: 10.1016/J.Ygeno.2003.09.002  0.63
2003 Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, ... ... Racette BA, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.Wnl.0000095966.99430.F4  0.585
2003 Racette BA, Good L, Sagitto S, Perlmutter JS. Botulinum toxin B reduces sialorrhea in parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1059-61. PMID 14502678 DOI: 10.1002/Mds.10484  0.532
2002 Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection Neurology. 59: 1445-1447. PMID 12427903 DOI: 10.1212/Wnl.59.9.1445  0.458
2002 Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 438-42. PMID 12426412 DOI: 10.1176/Jnp.14.4.438  0.799
2002 Racette BA, Stambuk M, Perlmutter JS. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024). Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1098-100. PMID 12360571 DOI: 10.1002/Mds.10209  0.447
2002 Racette BA, Rundle M, Wang JC, Goate A, Saccone NL, Farrer M, Lincoln S, Hussey J, Smemo S, Lin J, Suarez B, Parsian A, Perlmutter JS. A multi-incident, Old-Order Amish family with PD. Neurology. 58: 568-74. PMID 11865134 DOI: 10.1212/Wnl.58.4.568  0.636
2002 Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: Possible association with dementia but not age at onset Genomics. 79: 458-461. PMID 11863377 DOI: 10.1006/Geno.2002.6707  0.632
2001 Racette BA, Perry A, D'Avossa G, Perlmutter JS. Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum Movement Disorders. 16: 1148-1152. PMID 11748751 DOI: 10.1002/Mds.10012  0.508
2001 Racette BA, Dowling J, Randle J, Mink JW. Thalamic stimulation for primary writing tremor. Journal of Neurology. 248: 380-2. PMID 11437158 DOI: 10.1007/S004150170177  0.482
2001 Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 56: 8-13. PMID 11148228 DOI: 10.1212/Wnl.56.1.8  0.707
2000 Racette BA, Rich KM, Randle J, Mink JW. Ipsilateral thalamic stimulation after thalamotomy for essential tremor. A case report. Stereotactic and Functional Neurosurgery. 75: 155-9. PMID 11910208 DOI: 10.1159/000048400  0.487
2000 Racette BA, Rich KM, Randle J, Mink JW, Goto S, Hamasaki T, Nishikawa S, Okamura A, Yoshikawa M, Yamada K, Soyama N, Mita S, Ushio Y, Steinmeier R, Rachinger J, et al. Contents Vol. 75, 2000 Stereotactic and Functional Neurosurgery. 75: 205-205. DOI: 10.1159/000048408  0.432
2000 Racette BA, Rich KM, Randle J, Mink JW, Goto S, Hamasaki T, Nishikawa S, Okamura A, Yoshikawa M, Yamada K, Soyama N, Mita S, Ushio Y, Steinmeier R, Rachinger J, et al. Subject Index Vol. 75, 2000 Stereotactic and Functional Neurosurgery. 75: 204-204. DOI: 10.1159/000048407  0.465
1999 Racette BA, McGee-Minnich L, Perlmutter JS. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation Clinical Neuropharmacology. 22: 337-339. PMID 10626093  0.379
1999 Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 7: 169-74. PMID 10520242 DOI: 10.1076/Stra.7.3.169.636  0.545
1999 Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 88: 539-543. PMID 10490713 DOI: 10.1002/(Sici)1096-8628(19991015)88:5<539::Aid-Ajmg19>3.0.Co;2-S  0.636
1998 Parsian A, Racette B, Zhang ZH, Chakraverty S, Rundle M, Goate A, Perlmutter JS. Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease Neurology. 51: 1757-1759. PMID 9855543 DOI: 10.1212/Wnl.51.6.1757  0.589
1998 Racette BA, Perlmutter JS. Levodopa responsive parkinsonism in an adult with Huntington's disease Journal of Neurology Neurosurgery and Psychiatry. 65: 577-579. PMID 9771791 DOI: 10.1136/Jnnp.65.4.577  0.58
1998 Black KJ, Racette B, Perlmutter JS. Preventing contractions in neuroleptic malignant syndrome and dystonia [2] American Journal of Psychiatry. 155: 1298-1299. PMID 9734560 DOI: 10.1176/Ajp.155.9.1298A  0.601
1998 Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases Journal of Neurosurgery. 88: 328-330. PMID 9452245 DOI: 10.3171/Jns.1998.88.2.0328  0.46
Show low-probability matches.